SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-298602
Filing Date
2014-08-07
Accepted
2014-08-06 17:58:22
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d745140d10q.htm 10-Q 535138
2 EX-10.1 d745140dex101.htm EX-10.1 66101
3 EX-31.1 d745140dex311.htm EX-31.1 6844
4 EX-32.1 d745140dex321.htm EX-32.1 3926
  Complete submission text file 0001193125-14-298602.txt   4104717

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgls-20140630.xml EX-101.INS 545591
6 XBRL TAXONOMY EXTENSION SCHEMA rgls-20140630.xsd EX-101.SCH 37195
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgls-20140630_cal.xml EX-101.CAL 47068
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgls-20140630_def.xml EX-101.DEF 235644
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20140630_lab.xml EX-101.LAB 322844
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20140630_pre.xml EX-101.PRE 272637
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 141021116
SIC: 2834 Pharmaceutical Preparations